Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Feelmore Labs is an innovative health & wellness technology company.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Homeward is focused on improving access to high-quality, affordable primary and specialty care in rural communities.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.
Akamis Bio is a clinical-stage oncology company.
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Rippl Care is a mental health company committed to assisting seniors who suffer from dementia and other neurocognitive disorders.
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Over millions and millions of years, a collection of reward systems
Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.
Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, Kardigan received $254.0M in a Series B round. ARCH Venture Partners's total known invested capital is $28.0B.
ARCH Venture Partners's average investment size is $123.2M across its portfolio of 236 companies.
Recent ARCH Venture Partners portfolio additions include Feelmore Labs, Twist Bioscience, Chroma Medicine, Paratus Sciences, Vir Biotechnology. These companies were founded in 2020 or later.